These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37864259)
21. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling. Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812 [TBL] [Abstract][Full Text] [Related]
22. Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling. Cataltepe S; Arikan MC; Liang X; Smith TW; Cataltepe O Neuropathol Appl Neurobiol; 2015 Aug; 41(5):646-56. PubMed ID: 24865546 [TBL] [Abstract][Full Text] [Related]
23. Abnormal elastin and collagen deposition is present in extracranial arteriovenous malformations: A comparison to intracranial disease. Wei T; Shalin S; Draper E; Miller E; Zhang H; Sun R; Lee M; Albert G; Richter GT Histol Histopathol; 2019 Dec; 34(12):1355-1363. PubMed ID: 31119718 [TBL] [Abstract][Full Text] [Related]
24. Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model. Zhu W; Chen W; Zou D; Wang L; Bao C; Zhan L; Saw D; Wang S; Winkler E; Li Z; Zhang M; Shen F; Shaligram S; Lawton M; Su H Stroke; 2018 May; 49(5):1232-1240. PubMed ID: 29593101 [TBL] [Abstract][Full Text] [Related]
25. Expression of myosin heavy chain isoforms by smooth muscle cells in cerebral arteriovenous malformations. Hoya K; Asai A; Sasaki T; Nagata K; Kimura K; Kirino T Acta Neuropathol; 2003 May; 105(5):455-61. PubMed ID: 12677445 [TBL] [Abstract][Full Text] [Related]
26. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations. Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372 [TBL] [Abstract][Full Text] [Related]
27. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia. Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088 [TBL] [Abstract][Full Text] [Related]
28. Notch4 is activated in endothelial and smooth muscle cells in human brain arteriovenous malformations. ZhuGe Q; Wu Z; Huang L; Zhao B; Zhong M; Zheng W; GouRong C; Mao X; Xie L; Wang X; Jin K J Cell Mol Med; 2013 Nov; 17(11):1458-64. PubMed ID: 24373503 [TBL] [Abstract][Full Text] [Related]
29. Histopathologic and ultrasound characteristics of cutaneous capillary malformations in a patient with capillary malformation-arteriovenous malformation syndrome. Kim C; Ko CJ; Baker KE; Antaya RJ Pediatr Dermatol; 2015; 32(1):128-31. PubMed ID: 23829194 [TBL] [Abstract][Full Text] [Related]
30. Expression of transforming growth factor-beta complex in arteriovenous malformations. Malik G; Abdulrauf S; Yang XY; Gutierrez JA; Rempel SA Neurol Med Chir (Tokyo); 1998; 38 Suppl():161-4. PubMed ID: 10235000 [TBL] [Abstract][Full Text] [Related]
31. Follicle-Stimulating Hormone Receptor Expression in Endometriotic Lesions and the Associated Vasculature: An Immunohistochemical Study. Robin B; Planeix F; Sastre-Garau X; Pichon C; Olesen TK; Gogusev J; Ghinea N Reprod Sci; 2016 Jul; 23(7):885-91. PubMed ID: 26704526 [TBL] [Abstract][Full Text] [Related]
32. Targeting the microenvironment in the treatment of arteriovenous malformations. Seebauer CT; Wiens B; Hintschich CA; Platz Batista da Silva N; Evert K; Haubner F; Kapp FG; Wendl C; Renner K; Bohr C; Kühnel T; Vielsmeier V Angiogenesis; 2024 Feb; 27(1):91-103. PubMed ID: 37733132 [TBL] [Abstract][Full Text] [Related]
33. Endothelial cells in the context of brain arteriovenous malformations. Sammons V; Davidson A; Tu J; Stoodley MA J Clin Neurosci; 2011 Feb; 18(2):165-70. PubMed ID: 21167719 [TBL] [Abstract][Full Text] [Related]
34. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Pruthi D; McCurley A; Aronovitz M; Galayda C; Karumanchi SA; Jaffe IZ Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):355-64. PubMed ID: 24311380 [TBL] [Abstract][Full Text] [Related]
35. Histopathological hallmarks of cutaneous lesions of capillary malformation-arteriovenous malformation syndrome. Valdivielso-Ramos M; Torrelo A; Martin-Santiago A; Hernández-Nuñez A; Azaña JM; Campos M; Berenguer B; Garnacho G; Moreno R; Colmenero I J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2428-2435. PubMed ID: 32124491 [TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of arteriovenous malformations in the absence of endoglin. Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041 [TBL] [Abstract][Full Text] [Related]
37. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model. Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395 [TBL] [Abstract][Full Text] [Related]